London · Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 58.51 billion. The enterprise value is 71.81 billion.
| Market Cap | 58.51B |
| Enterprise Value | 71.81B |
Important Dates
The next estimated earnings date is Wednesday, October 29, 2025.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
GSK plc has 4.03 billion shares outstanding. The number of shares has increased by 0.49% in one year.
| Current Share Class | 4.03B |
| Shares Outstanding | 4.03B |
| Shares Change (YoY) | +0.49% |
| Shares Change (QoQ) | -0.65% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 89.65% |
| Float | 3.89B |
Valuation Ratios
The trailing PE ratio is 17.58 and the forward PE ratio is 8.47. GSK plc's PEG ratio is 1.37.
| PE Ratio | 17.58 |
| Forward PE | 8.47 |
| PS Ratio | 1.85 |
| PB Ratio | 4.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.13 |
| P/OCF Ratio | 7.58 |
| PEG Ratio | 1.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.56, with an EV/FCF ratio of 11.20.
| EV / Earnings | 20.98 |
| EV / Sales | 2.27 |
| EV / EBITDA | 7.56 |
| EV / EBIT | 11.28 |
| EV / FCF | 11.20 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.21.
| Current Ratio | 0.87 |
| Quick Ratio | 0.56 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | 1.83 |
| Debt / FCF | 2.71 |
| Interest Coverage | 10.25 |
Financial Efficiency
Return on equity (ROE) is 28.33% and return on invested capital (ROIC) is 12.75%.
| Return on Equity (ROE) | 28.33% |
| Return on Assets (ROA) | 6.78% |
| Return on Invested Capital (ROIC) | 12.75% |
| Return on Capital Employed (ROCE) | 16.38% |
| Revenue Per Employee | 460,898 |
| Profits Per Employee | 49,877 |
| Employee Count | 68,629 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.50 |
Taxes
In the past 12 months, GSK plc has paid 638.00 million in taxes.
| Income Tax | 638.00M |
| Effective Tax Rate | 13.80% |
Stock Price Statistics
The stock price has decreased by -12.05% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -12.05% |
| 50-Day Moving Average | 1,413.61 |
| 200-Day Moving Average | 1,409.80 |
| Relative Strength Index (RSI) | 54.23 |
| Average Volume (20 Days) | 7,397,296 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 31.63 billion and earned 3.42 billion in profits. Earnings per share was 0.83.
| Revenue | 31.63B |
| Gross Profit | 22.68B |
| Operating Income | 6.37B |
| Pretax Income | 4.62B |
| Net Income | 3.42B |
| EBITDA | 9.29B |
| EBIT | 6.37B |
| Earnings Per Share (EPS) | 0.83 |
Balance Sheet
The company has 3.62 billion in cash and 17.35 billion in debt, giving a net cash position of -13.74 billion or -3.41 per share.
| Cash & Cash Equivalents | 3.62B |
| Total Debt | 17.35B |
| Net Cash | -13.74B |
| Net Cash Per Share | -3.41 |
| Equity (Book Value) | 14.35B |
| Book Value Per Share | 3.65 |
| Working Capital | -2.71B |
Cash Flow
In the last 12 months, operating cash flow was 7.72 billion and capital expenditures -1.31 billion, giving a free cash flow of 6.41 billion.
| Operating Cash Flow | 7.72B |
| Capital Expenditures | -1.31B |
| Free Cash Flow | 6.41B |
| FCF Per Share | 1.59 |
Margins
Gross margin is 71.69%, with operating and profit margins of 20.13% and 10.82%.
| Gross Margin | 71.69% |
| Operating Margin | 20.13% |
| Pretax Margin | 14.61% |
| Profit Margin | 10.82% |
| EBITDA Margin | 29.37% |
| EBIT Margin | 20.13% |
| FCF Margin | 20.27% |
Dividends & Yields
This stock pays an annual dividend of 0.61, which amounts to a dividend yield of 4.20%.
| Dividend Per Share | 0.61 |
| Dividend Yield | 4.20% |
| Dividend Growth (YoY) | 5.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 72.80% |
| Buyback Yield | -0.49% |
| Shareholder Yield | 3.71% |
| Earnings Yield | 5.85% |
| FCF Yield | 10.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.83 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.83 |
| Piotroski F-Score | 6 |